Fig. 1. CM-AI automated detection of CMs and laser ablation of non-myocytes in 2D monolayers.
a Step 1 in this hiPSC-CM enrichment process is to acquire a phase contrast image of a well of cardiac differentiation with AI detection of CM colonies (red). b Step 2 in this easy-to-use process is replating enriched hiPSC-CMs. c Phase contrast and fluorescent imaging of GFP+ CMs enrichment in 2D monolayers. Successful AI recognition of CMs in phase contrast images was validated using time-lapse imaging of monolayers pre-AI laser processing and post-AI laser processing. The overall GFP confluence did decrease significantly in six independent wells processed using CM-AI-laser ablation of the non-myocyte (GFP-) cell population (Pre GFP confluence = 11.23 ± 3.2%; Post GFP confluence = 8.88 ± 2.4%; n = 6 paired t-test, **P = 0.009). The green Mask was used for quantification of the GFP confluence area before and after CM-AI laser processing. d Validation of CM enrichment in replated monolayers. Following CM-AI laser processing and CM enrichment, CMs were replated on CELLvo™ MatrixPlus human ECM-coated plates for analysis. CM-AI laser-processed wells reached purity (>85%) levels significantly greater than unprocessed wells. (n = 4 monolayers per group; unpaired t-test; ****P < 0.0001).
